Active Ingredient: CHLOROTHIAZIDE; RESERPINE
Proprietary Name: CHLOROTHIAZIDE W/ RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;0.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A088151
Product Number: 001
Approval Date: Jun 9, 1983
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information